Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXSL2300260 | 注射用培重组人凝血因子IX-Fc融合蛋白 | Lyophilized | Biological Products(1) | New Drug Application | 2023-04-14 | Zhengzhou Shengsi Biotechnology Co Ltd | view | ||||
CXSL2300259 | 注射用培重组人凝血因子IX-Fc融合蛋白 | Lyophilized | Biological Products(1) | New Drug Application | 2023-04-14 | Zhengzhou Shengsi Biotechnology Co Ltd | view |